Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre Etchegaray

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Molecular Cell|June 4, 2016
Interplay between Metabolism and Epigenetics: A Nuclear Adaptation to Environmental ChangesJean-Pierre Etchegaray, Raul Mostoslavsky
The Journal of Biological Chemistry|July 15, 2018
A sirtuin's role in preventing senescence by protecting ribosomal DNAJean-Pierre Etchegaray, Raul Mostoslavsky
Cell Stem Cell|October 11, 2011
eNERgizing pluripotent gene transcriptionJean-Pierre Etchegaray, Raul Mostoslavsky
Current Topics in Medicinal Chemistry|November 1, 2013
The histone deacetylase SIRT6: at the crossroads between epigenetics, metabolism and diseaseJean-Pierre Etchegaray, Lei Zhong, Raul Mostoslavsky
Cancers|December 9, 2020
Non-Coding RNAs as Mediators of Epigenetic Changes in MalignanciesSubhasree Kumar, Edward A Gonzalez, Pranela Rameshwar, et al.
Nature|December 17, 2002
Rhythmic histone acetylation underlies transcription in the mammalian circadian clockJean-Pierre Etchegaray, Choogon Lee, Paul A Wade, et al.
Cancer Metastasis Reviews|May 13, 2020
Epigenetic dynamics in cancer stem cell dormancyAlejandra I Ferrer, Jonathan R Trinidad, Oleta Sandiford, et al.
Plos One|April 28, 2010
Casein kinase 1 delta (CK1delta) regulates period length of the mouse suprachiasmatic circadian clock in vitroJean-Pierre Etchegaray, Elizabeth A Yu, Premananda Indic, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2011
The period of the circadian oscillator is primarily determined by the balance between casein kinase 1 and protein phosphatase 1Hyeong-min Lee, Rongmin Chen, Hyukmin Kim, et al.
Pharmaceuticals (Basel, Switzerland)|August 6, 2021
Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid LeukemiaVincent G Sorrentino, Srijan Thota, Edward A Gonzalez, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Molecular Cell|June 4, 2016
Interplay between Metabolism and Epigenetics: A Nuclear Adaptation to Environmental ChangesJean-Pierre Etchegaray, Raul Mostoslavsky
The Journal of Biological Chemistry|July 15, 2018
A sirtuin's role in preventing senescence by protecting ribosomal DNAJean-Pierre Etchegaray, Raul Mostoslavsky
Cell Stem Cell|October 11, 2011
eNERgizing pluripotent gene transcriptionJean-Pierre Etchegaray, Raul Mostoslavsky
Current Topics in Medicinal Chemistry|November 1, 2013
The histone deacetylase SIRT6: at the crossroads between epigenetics, metabolism and diseaseJean-Pierre Etchegaray, Lei Zhong, Raul Mostoslavsky
Cancers|December 9, 2020
Non-Coding RNAs as Mediators of Epigenetic Changes in MalignanciesSubhasree Kumar, Edward A Gonzalez, Pranela Rameshwar, et al.
Nature|December 17, 2002
Rhythmic histone acetylation underlies transcription in the mammalian circadian clockJean-Pierre Etchegaray, Choogon Lee, Paul A Wade, et al.
Cancer Metastasis Reviews|May 13, 2020
Epigenetic dynamics in cancer stem cell dormancyAlejandra I Ferrer, Jonathan R Trinidad, Oleta Sandiford, et al.
Plos One|April 28, 2010
Casein kinase 1 delta (CK1delta) regulates period length of the mouse suprachiasmatic circadian clock in vitroJean-Pierre Etchegaray, Elizabeth A Yu, Premananda Indic, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2011
The period of the circadian oscillator is primarily determined by the balance between casein kinase 1 and protein phosphatase 1Hyeong-min Lee, Rongmin Chen, Hyukmin Kim, et al.
Pharmaceuticals (Basel, Switzerland)|August 6, 2021
Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid LeukemiaVincent G Sorrentino, Srijan Thota, Edward A Gonzalez, et al.
Pageof 3